The World Health Organization (WHO) has launched a $1.5bn emergency appeal to tackle “unprecedented” global health crises.
Novo Nordisk has shared positive headline results from a late-stage study evaluating a higher dose of its GLP-1 receptor ...
Valneva has shared positive results from a late-stage study of its single-dose chikungunya vaccine in adolescents aged 12 to ...
At this year’s ISMPP conference, we’re speaking from the heart. Our ‘We Love Pubs’ booth theme has been designed to reflect ...